SlideShare a Scribd company logo
1 of 25
#SXSW #games4good @HopeLab
Gaming for Good
Fred Dillon
Director of Product Development
HopeLab
@FredDillon .
#SXSW #games4good @HopeLab
#SXSW #games4good @HopeLab
#SXSW #games4good @HopeLab
#SXSW #games4good @HopeLab
#SXSW #games4good @HopeLab
#SXSW #games4good @HopeLab
Cancer Knowledge
Baseline Follow-up
Intervention-targetedknowledge(%correct)
Control
Re-Mission
55
60
65
70
Self-Efficacy
Cancer-specificself-efficacy(1-7scale)
5.6
5.8
6.0
6.2
Baseline Follow-up
Control
Re-Mission
p = .034 p = .027
30
40
CapEvents
Antibiotics
p = .008
P(log10)
Re-Mission
Chemotherapy: Oral 6MP
p = .002
3.6
3.8
r Knowledge
line Follow-up
Control
Re-Mission
Self-Efficacy
Cancer-specificself-efficacy(1-7scale)
5.6
5.8
6.0
6.2
Baseline Follow-up
Control
Re-Mission
= .034 p = .027
ntibiotics
p = .008
P(log10)
Re-Mission
Chemotherapy: Oral 6MP
p = .002
3.6
3.8
Baseline Follow-up
Intervention-targetedknowl
Control
Re-Mission
55
60
65
Cancer-specificself-effica
5.6
5.8
6.0
Base
0
10
20
30
40
TotalMEMSCapEvents
Control
Antibiotics
p = .008
Plasma6MP(log10)
Chemo
3.2
3.4
3.6
3.8
Base
Baseline Follow-up
Intervention-targetedknowl
Control
Re-Mission
55
60
65
Cancer-specificself-effica
5.6
5.8
6.0
Baseline Follow-up
Control
Re-Mission
0
10
20
30
40
TotalMEMSCapEvents
Control
Antibiotics
p = .008
Plasma6MP(log10)
Control
Re-Mission
Chemotherapy: Oral 6MP
p = .002
3.2
3.4
3.6
3.8
Baseline Follow-up
#SXSW #games4good @HopeLab
Pediatrics – August 2008
Re-Mission Outcomes Study RCT
34 hospitals, 375 AYA with cancer
Cancer Knowledge
Baseline Follow-up
Intervention-targetedknowledge(%correct)
Control
Re-Mission
55
60
65
70
Self-Efficacy
Cancer-specificself-efficacy(1-7scale)
5.6
5.8
6.0
6.2
Baseline Follow-up
Control
Re-Mission
p = .034 p = .027
30
40
CapEvents
Antibiotics
p = .008
P(log10)
Re-Mission
Chemotherapy: Oral 6MP
p = .002
3.6
3.8
r Knowledge
line Follow-up
Control
Re-Mission
Self-Efficacy
Cancer-specificself-efficacy(1-7scale)
5.6
5.8
6.0
6.2
Baseline Follow-up
Control
Re-Mission
= .034 p = .027
ntibiotics
p = .008
P(log10)
Re-Mission
Chemotherapy: Oral 6MP
p = .002
3.6
3.8
Baseline Follow-up
Intervention-targetedknowl
Control
Re-Mission
55
60
65
Cancer-specificself-effica
5.6
5.8
6.0
Base
0
10
20
30
40
TotalMEMSCapEvents
Control
Antibiotics
p = .008
Plasma6MP(log10)
Chemo
3.2
3.4
3.6
3.8
Base
Baseline Follow-up
Intervention-targetedknowl
Control
Re-Mission
55
60
65
Cancer-specificself-effica
5.6
5.8
6.0
Baseline Follow-up
Control
Re-Mission
0
10
20
30
40
TotalMEMSCapEvents
Control
Antibiotics
p = .008
Plasma6MP(log10)
Control
Re-Mission
Chemotherapy: Oral 6MP
p = .002
3.2
3.4
3.6
3.8
Baseline Follow-up
#SXSW #games4good @HopeLab
Pediatrics – August 2008
Re-Mission Outcomes Study RCT
34 hospitals, 375 AYA with cancer
Cancer Knowledge
Baseline Follow-up
Intervention-targetedknowledge(%correct)
Control
Re-Mission
55
60
65
70
Self-Efficacy
Cancer-specificself-efficacy(1-7scale)
5.6
5.8
6.0
6.2
Baseline Follow-up
Control
Re-Mission
p = .034 p = .027
30
40
CapEvents
Antibiotics
p = .008
P(log10)
Re-Mission
Chemotherapy: Oral 6MP
p = .002
3.6
3.8
r Knowledge
line Follow-up
Control
Re-Mission
Self-Efficacy
Cancer-specificself-efficacy(1-7scale)
5.6
5.8
6.0
6.2
Baseline Follow-up
Control
Re-Mission
= .034 p = .027
ntibiotics
p = .008
P(log10)
Re-Mission
Chemotherapy: Oral 6MP
p = .002
3.6
3.8
Baseline Follow-up
Intervention-targetedknowl
Control
Re-Mission
55
60
65
Cancer-specificself-effica
5.6
5.8
6.0
Base
0
10
20
30
40
TotalMEMSCapEvents
Control
Antibiotics
p = .008
Plasma6MP(log10)
Chemo
3.2
3.4
3.6
3.8
Base
Baseline Follow-up
Intervention-targetedknowl
Control
Re-Mission
55
60
65
Cancer-specificself-effica
5.6
5.8
6.0
Baseline Follow-up
Control
Re-Mission
0
10
20
30
40
TotalMEMSCapEvents
Control
Antibiotics
p = .008
Plasma6MP(log10)
Control
Re-Mission
Chemotherapy: Oral 6MP
p = .002
3.2
3.4
3.6
3.8
Baseline Follow-up
#SXSW #games4good @HopeLab
Pediatrics – August 2008
Re-Mission Outcomes Study RCT
34 hospitals, 375 AYA with cancer
Cancer Knowledge
Baseline Follow-up
Intervention-targetedknowledge(%correct)
Control
Re-Mission
55
60
65
70
Self-Efficacy
Cancer-specificself-efficacy(1-7scale)
5.6
5.8
6.0
6.2
Baseline Follow-up
Control
Re-Mission
p = .034 p = .027
30
40
CapEvents
Antibiotics
p = .008
P(log10)
Re-Mission
Chemotherapy: Oral 6MP
p = .002
3.6
3.8
r Knowledge
line Follow-up
Control
Re-Mission
Self-Efficacy
Cancer-specificself-efficacy(1-7scale)
5.6
5.8
6.0
6.2
Baseline Follow-up
Control
Re-Mission
= .034 p = .027
ntibiotics
p = .008
P(log10)
Re-Mission
Chemotherapy: Oral 6MP
p = .002
3.6
3.8
Baseline Follow-up
Intervention-targetedknowl
Control
Re-Mission
55
60
65
Cancer-specificself-effica
5.6
5.8
6.0
Base
0
10
20
30
40
TotalMEMSCapEvents
Control
Antibiotics
p = .008
Plasma6MP(log10)
Chemo
3.2
3.4
3.6
3.8
Base
Baseline Follow-up
Intervention-targetedknowl
Control
Re-Mission
55
60
65
Cancer-specificself-effica
5.6
5.8
6.0
Baseline Follow-up
Control
Re-Mission
0
10
20
30
40
TotalMEMSCapEvents
Control
Antibiotics
p = .008
Plasma6MP(log10)
Control
Re-Mission
Chemotherapy: Oral 6MP
p = .002
3.2
3.4
3.6
3.8
Baseline Follow-up
#SXSW #games4good @HopeLab
Pediatrics – August 2008
Re-Mission Outcomes Study RCT
34 hospitals, 375 AYA with cancer
PLOS ONE – March 2012
Re-Mission Attitudes Study
#SXSW #games4good @HopeLab
Playing
PLOS ONE – March 2012
Re-Mission Attitudes Study
#SXSW #games4good @HopeLab
Motivation
Excitement
Memory
Playing
PLOS ONE – March 2012
Re-Mission Attitudes Study
#SXSW #games4good @HopeLab
Watching
Motivation
Excitement
Memory
#SXSW #games4good @HopeLab
#SXSW #games4good @HopeLab
? … … … … …
“I want to see the
cancer blown up
and vaporized!”
#SXSW #games4good @HopeLab
“I want to
watch cancer
squirm and
suffer!”
“Cancer is power
hungry. It’s not
satisfied with what
it’s got, it always
wants more.”
“[Cancer] sits there
and eats and takes
from you and does
nothing but eat and
replicate.”
#SXSW #games4good @HopeLab
Cat God vs. Sun King
#SXSW #games4good @HopeLab
#SXSW #games4good @HopeLab
Thank you!
.org

More Related Content

Viewers also liked

Zamzee Poster Presentation - Global Summit on the Physical Activity of Children
Zamzee Poster Presentation - Global Summit on the Physical Activity of ChildrenZamzee Poster Presentation - Global Summit on the Physical Activity of Children
Zamzee Poster Presentation - Global Summit on the Physical Activity of ChildrenHopeLab
 
Sense and sentimentality in digital stories – a case of pre-service teacher e...
Sense and sentimentality in digital stories – a case of pre-service teacher e...Sense and sentimentality in digital stories – a case of pre-service teacher e...
Sense and sentimentality in digital stories – a case of pre-service teacher e...Daniela Gachago
 
Storytelling, emotions and empathy
 Storytelling, emotions and empathy Storytelling, emotions and empathy
Storytelling, emotions and empathyDaniela Gachago
 
Cultivating an Innovative Organization
Cultivating an Innovative OrganizationCultivating an Innovative Organization
Cultivating an Innovative OrganizationHopeLab
 
Designing for Resilience and Compassionate Action
Designing for Resilience and Compassionate ActionDesigning for Resilience and Compassionate Action
Designing for Resilience and Compassionate ActionHopeLab
 
Hl check in_deck_ebook_20140117
Hl check in_deck_ebook_20140117Hl check in_deck_ebook_20140117
Hl check in_deck_ebook_20140117HopeLab
 
Resilience Through Tech: Designing to Help People (Presented at SXSW 2015)
Resilience Through Tech: Designing to Help People (Presented at SXSW 2015)Resilience Through Tech: Designing to Help People (Presented at SXSW 2015)
Resilience Through Tech: Designing to Help People (Presented at SXSW 2015)HopeLab
 
Resilience tech
Resilience techResilience tech
Resilience techHopeLab
 
Chapter 1 Observation Skills
Chapter 1 Observation SkillsChapter 1 Observation Skills
Chapter 1 Observation Skillswatsonma12
 
Observation skills
Observation skillsObservation skills
Observation skillsreachrubi27
 
We Are Social's Guide To Building A Connected Strategy
We Are Social's Guide To Building A Connected StrategyWe Are Social's Guide To Building A Connected Strategy
We Are Social's Guide To Building A Connected StrategyWe Are Social Singapore
 
Designing with Empathy [Code & Creativity 2014]
Designing with Empathy [Code & Creativity 2014]Designing with Empathy [Code & Creativity 2014]
Designing with Empathy [Code & Creativity 2014]Aaron Gustafson
 

Viewers also liked (15)

Zamzee Poster Presentation - Global Summit on the Physical Activity of Children
Zamzee Poster Presentation - Global Summit on the Physical Activity of ChildrenZamzee Poster Presentation - Global Summit on the Physical Activity of Children
Zamzee Poster Presentation - Global Summit on the Physical Activity of Children
 
Sense and sentimentality in digital stories – a case of pre-service teacher e...
Sense and sentimentality in digital stories – a case of pre-service teacher e...Sense and sentimentality in digital stories – a case of pre-service teacher e...
Sense and sentimentality in digital stories – a case of pre-service teacher e...
 
Storytelling, emotions and empathy
 Storytelling, emotions and empathy Storytelling, emotions and empathy
Storytelling, emotions and empathy
 
Cultivating an Innovative Organization
Cultivating an Innovative OrganizationCultivating an Innovative Organization
Cultivating an Innovative Organization
 
Designing for Resilience and Compassionate Action
Designing for Resilience and Compassionate ActionDesigning for Resilience and Compassionate Action
Designing for Resilience and Compassionate Action
 
Hl check in_deck_ebook_20140117
Hl check in_deck_ebook_20140117Hl check in_deck_ebook_20140117
Hl check in_deck_ebook_20140117
 
Resilience Through Tech: Designing to Help People (Presented at SXSW 2015)
Resilience Through Tech: Designing to Help People (Presented at SXSW 2015)Resilience Through Tech: Designing to Help People (Presented at SXSW 2015)
Resilience Through Tech: Designing to Help People (Presented at SXSW 2015)
 
Resilience tech
Resilience techResilience tech
Resilience tech
 
Empathy
EmpathyEmpathy
Empathy
 
Chapter 1 Observation Skills
Chapter 1 Observation SkillsChapter 1 Observation Skills
Chapter 1 Observation Skills
 
Observation skills
Observation skillsObservation skills
Observation skills
 
We Are Social's Guide To Building A Connected Strategy
We Are Social's Guide To Building A Connected StrategyWe Are Social's Guide To Building A Connected Strategy
We Are Social's Guide To Building A Connected Strategy
 
Designing with Empathy [Code & Creativity 2014]
Designing with Empathy [Code & Creativity 2014]Designing with Empathy [Code & Creativity 2014]
Designing with Empathy [Code & Creativity 2014]
 
Digital in 2017 Global Overview
Digital in 2017 Global OverviewDigital in 2017 Global Overview
Digital in 2017 Global Overview
 
Digital in 2016
Digital in 2016Digital in 2016
Digital in 2016
 

Similar to Gaming for Good: Using Games to Create Change (Presented at SXSW 2015)

Enabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to CombinationsEnabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to CombinationsDiscoverX Corporation
 
Probes 2010
Probes 2010Probes 2010
Probes 2010toluene
 
Clinical Proof of Concept (PoC)
Clinical Proof of Concept (PoC)Clinical Proof of Concept (PoC)
Clinical Proof of Concept (PoC)Cytel USA
 
Joseph Gligorov : Lipegfilgrastim : A new long-ac,ng recombinant human G-CSF
Joseph Gligorov : Lipegfilgrastim :  A new long-ac,ng recombinant human G-CSFJoseph Gligorov : Lipegfilgrastim :  A new long-ac,ng recombinant human G-CSF
Joseph Gligorov : Lipegfilgrastim : A new long-ac,ng recombinant human G-CSFbreastcancerupdatecongress
 
2015 11-26 ODDP2015 Course Oncology Drug Development, Amsterdam, Alain van Gool
2015 11-26 ODDP2015 Course Oncology Drug Development, Amsterdam, Alain van Gool2015 11-26 ODDP2015 Course Oncology Drug Development, Amsterdam, Alain van Gool
2015 11-26 ODDP2015 Course Oncology Drug Development, Amsterdam, Alain van GoolAlain van Gool
 
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...CrimsonpublishersNTNF
 
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...isrodoy isr
 
Gene Profiling in Clinical Oncology - Slide 10 - H. Rugo - Why genomic tools ...
Gene Profiling in Clinical Oncology - Slide 10 - H. Rugo - Why genomic tools ...Gene Profiling in Clinical Oncology - Slide 10 - H. Rugo - Why genomic tools ...
Gene Profiling in Clinical Oncology - Slide 10 - H. Rugo - Why genomic tools ...European School of Oncology
 
Long Acting Injectables - A New Dimension for Proteins and Peptides
Long Acting Injectables - A New Dimension for Proteins and PeptidesLong Acting Injectables - A New Dimension for Proteins and Peptides
Long Acting Injectables - A New Dimension for Proteins and PeptidesMilliporeSigma
 
Long Acting Injectables - A New Dimension for Proteins and Peptides
Long Acting Injectables - A New Dimension for Proteins and PeptidesLong Acting Injectables - A New Dimension for Proteins and Peptides
Long Acting Injectables - A New Dimension for Proteins and PeptidesMerck Life Sciences
 
Bigger Data to Increase Drug Discovery
Bigger Data to Increase Drug DiscoveryBigger Data to Increase Drug Discovery
Bigger Data to Increase Drug DiscoverySean Ekins
 
Target Validation Academy Of Medical Sciences 1 Dec 2006
Target Validation   Academy Of Medical Sciences 1 Dec 2006Target Validation   Academy Of Medical Sciences 1 Dec 2006
Target Validation Academy Of Medical Sciences 1 Dec 2006Mike Romanos
 
mHealth Israel_Startup Contest Finalist_Biop Medical_one pager
mHealth Israel_Startup Contest Finalist_Biop Medical_one pagermHealth Israel_Startup Contest Finalist_Biop Medical_one pager
mHealth Israel_Startup Contest Finalist_Biop Medical_one pagerLevi Shapiro
 
ppt oncology
ppt oncologyppt oncology
ppt oncologykahnghapt
 
How I treat Relapsed Ca Ovary
How I treat Relapsed Ca OvaryHow I treat Relapsed Ca Ovary
How I treat Relapsed Ca OvaryChandan K Das
 
Workflows supporting drug discovery against malaria
Workflows supporting drug discovery against malariaWorkflows supporting drug discovery against malaria
Workflows supporting drug discovery against malariaBarry Hardy
 
FOLLICULAR LYMPHOMA; UPDATES ON TREATMENT STRATEGIES
FOLLICULAR LYMPHOMA; UPDATES  ON TREATMENT STRATEGIESFOLLICULAR LYMPHOMA; UPDATES  ON TREATMENT STRATEGIES
FOLLICULAR LYMPHOMA; UPDATES ON TREATMENT STRATEGIESspa718
 

Similar to Gaming for Good: Using Games to Create Change (Presented at SXSW 2015) (20)

Enabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to CombinationsEnabling Cancer Immunotherapy: From Discovery to Combinations
Enabling Cancer Immunotherapy: From Discovery to Combinations
 
Probes 2010
Probes 2010Probes 2010
Probes 2010
 
Clinical Proof of Concept (PoC)
Clinical Proof of Concept (PoC)Clinical Proof of Concept (PoC)
Clinical Proof of Concept (PoC)
 
Joseph Gligorov : Lipegfilgrastim : A new long-ac,ng recombinant human G-CSF
Joseph Gligorov : Lipegfilgrastim :  A new long-ac,ng recombinant human G-CSFJoseph Gligorov : Lipegfilgrastim :  A new long-ac,ng recombinant human G-CSF
Joseph Gligorov : Lipegfilgrastim : A new long-ac,ng recombinant human G-CSF
 
2015 11-26 ODDP2015 Course Oncology Drug Development, Amsterdam, Alain van Gool
2015 11-26 ODDP2015 Course Oncology Drug Development, Amsterdam, Alain van Gool2015 11-26 ODDP2015 Course Oncology Drug Development, Amsterdam, Alain van Gool
2015 11-26 ODDP2015 Course Oncology Drug Development, Amsterdam, Alain van Gool
 
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
Quality Criteria Establishment for Dissolution of Ascorbic Acid from Sustaine...
 
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...
 
Gene Profiling in Clinical Oncology - Slide 10 - H. Rugo - Why genomic tools ...
Gene Profiling in Clinical Oncology - Slide 10 - H. Rugo - Why genomic tools ...Gene Profiling in Clinical Oncology - Slide 10 - H. Rugo - Why genomic tools ...
Gene Profiling in Clinical Oncology - Slide 10 - H. Rugo - Why genomic tools ...
 
Land mark trials gastric cancer
Land mark trials gastric cancerLand mark trials gastric cancer
Land mark trials gastric cancer
 
PMED Opening Workshop - FDA Panel - Issues in Trial Design & Analysis of CBER...
PMED Opening Workshop - FDA Panel - Issues in Trial Design & Analysis of CBER...PMED Opening Workshop - FDA Panel - Issues in Trial Design & Analysis of CBER...
PMED Opening Workshop - FDA Panel - Issues in Trial Design & Analysis of CBER...
 
Long Acting Injectables - A New Dimension for Proteins and Peptides
Long Acting Injectables - A New Dimension for Proteins and PeptidesLong Acting Injectables - A New Dimension for Proteins and Peptides
Long Acting Injectables - A New Dimension for Proteins and Peptides
 
Long Acting Injectables - A New Dimension for Proteins and Peptides
Long Acting Injectables - A New Dimension for Proteins and PeptidesLong Acting Injectables - A New Dimension for Proteins and Peptides
Long Acting Injectables - A New Dimension for Proteins and Peptides
 
Bigger Data to Increase Drug Discovery
Bigger Data to Increase Drug DiscoveryBigger Data to Increase Drug Discovery
Bigger Data to Increase Drug Discovery
 
Target Validation Academy Of Medical Sciences 1 Dec 2006
Target Validation   Academy Of Medical Sciences 1 Dec 2006Target Validation   Academy Of Medical Sciences 1 Dec 2006
Target Validation Academy Of Medical Sciences 1 Dec 2006
 
mHealth Israel_Startup Contest Finalist_Biop Medical_one pager
mHealth Israel_Startup Contest Finalist_Biop Medical_one pagermHealth Israel_Startup Contest Finalist_Biop Medical_one pager
mHealth Israel_Startup Contest Finalist_Biop Medical_one pager
 
Cco keynote 407
Cco keynote 407Cco keynote 407
Cco keynote 407
 
ppt oncology
ppt oncologyppt oncology
ppt oncology
 
How I treat Relapsed Ca Ovary
How I treat Relapsed Ca OvaryHow I treat Relapsed Ca Ovary
How I treat Relapsed Ca Ovary
 
Workflows supporting drug discovery against malaria
Workflows supporting drug discovery against malariaWorkflows supporting drug discovery against malaria
Workflows supporting drug discovery against malaria
 
FOLLICULAR LYMPHOMA; UPDATES ON TREATMENT STRATEGIES
FOLLICULAR LYMPHOMA; UPDATES  ON TREATMENT STRATEGIESFOLLICULAR LYMPHOMA; UPDATES  ON TREATMENT STRATEGIES
FOLLICULAR LYMPHOMA; UPDATES ON TREATMENT STRATEGIES
 

More from HopeLab

Resilience Through Tech
Resilience Through TechResilience Through Tech
Resilience Through TechHopeLab
 
Molecular self-awareness
Molecular self-awareness Molecular self-awareness
Molecular self-awareness HopeLab
 
Questions for a Curious Leader
Questions for a Curious LeaderQuestions for a Curious Leader
Questions for a Curious LeaderHopeLab
 
Check-in Deck, by Chris Marcell Murchison of HopeLab
Check-in Deck, by Chris Marcell Murchison of HopeLabCheck-in Deck, by Chris Marcell Murchison of HopeLab
Check-in Deck, by Chris Marcell Murchison of HopeLabHopeLab
 
Zamzee Research Results
Zamzee Research ResultsZamzee Research Results
Zamzee Research ResultsHopeLab
 
WizBiz Fortune Teller How To
WizBiz Fortune Teller How ToWizBiz Fortune Teller How To
WizBiz Fortune Teller How ToHopeLab
 
fMRI Results
fMRI ResultsfMRI Results
fMRI ResultsHopeLab
 
CES 2010 Kids@Play
CES 2010 Kids@PlayCES 2010 Kids@Play
CES 2010 Kids@PlayHopeLab
 
CES 2010 Engaging Customers To Improve Lives
CES 2010 Engaging Customers To Improve LivesCES 2010 Engaging Customers To Improve Lives
CES 2010 Engaging Customers To Improve LivesHopeLab
 
Sports 4 Kids
Sports 4 KidsSports 4 Kids
Sports 4 KidsHopeLab
 
Hope Lab Games For Health Presentation
Hope Lab Games For Health PresentationHope Lab Games For Health Presentation
Hope Lab Games For Health PresentationHopeLab
 

More from HopeLab (11)

Resilience Through Tech
Resilience Through TechResilience Through Tech
Resilience Through Tech
 
Molecular self-awareness
Molecular self-awareness Molecular self-awareness
Molecular self-awareness
 
Questions for a Curious Leader
Questions for a Curious LeaderQuestions for a Curious Leader
Questions for a Curious Leader
 
Check-in Deck, by Chris Marcell Murchison of HopeLab
Check-in Deck, by Chris Marcell Murchison of HopeLabCheck-in Deck, by Chris Marcell Murchison of HopeLab
Check-in Deck, by Chris Marcell Murchison of HopeLab
 
Zamzee Research Results
Zamzee Research ResultsZamzee Research Results
Zamzee Research Results
 
WizBiz Fortune Teller How To
WizBiz Fortune Teller How ToWizBiz Fortune Teller How To
WizBiz Fortune Teller How To
 
fMRI Results
fMRI ResultsfMRI Results
fMRI Results
 
CES 2010 Kids@Play
CES 2010 Kids@PlayCES 2010 Kids@Play
CES 2010 Kids@Play
 
CES 2010 Engaging Customers To Improve Lives
CES 2010 Engaging Customers To Improve LivesCES 2010 Engaging Customers To Improve Lives
CES 2010 Engaging Customers To Improve Lives
 
Sports 4 Kids
Sports 4 KidsSports 4 Kids
Sports 4 Kids
 
Hope Lab Games For Health Presentation
Hope Lab Games For Health PresentationHope Lab Games For Health Presentation
Hope Lab Games For Health Presentation
 

Recently uploaded

Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 365Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 3652toLead Limited
 
The Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and ConsThe Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and ConsPixlogix Infotech
 
"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii SoldatenkoFwdays
 
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada
 
How to write a Business Continuity Plan
How to write a Business Continuity PlanHow to write a Business Continuity Plan
How to write a Business Continuity PlanDatabarracks
 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationSlibray Presentation
 
Transcript: New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024Transcript: New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024BookNet Canada
 
What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024Stephanie Beckett
 
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada
 
SAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptxSAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptxNavinnSomaal
 
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptxThe Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptxLoriGlavin3
 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningLars Bell
 
DevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsDevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsSergiu Bodiu
 
WordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your BrandWordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your Brandgvaughan
 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupFlorian Wilhelm
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsRizwan Syed
 
Gen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfGen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfAddepto
 
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek SchlawackFwdays
 
Digital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptxDigital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptxLoriGlavin3
 

Recently uploaded (20)

Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 365Ensuring Technical Readiness For Copilot in Microsoft 365
Ensuring Technical Readiness For Copilot in Microsoft 365
 
DMCC Future of Trade Web3 - Special Edition
DMCC Future of Trade Web3 - Special EditionDMCC Future of Trade Web3 - Special Edition
DMCC Future of Trade Web3 - Special Edition
 
The Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and ConsThe Ultimate Guide to Choosing WordPress Pros and Cons
The Ultimate Guide to Choosing WordPress Pros and Cons
 
"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko"Debugging python applications inside k8s environment", Andrii Soldatenko
"Debugging python applications inside k8s environment", Andrii Soldatenko
 
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
 
How to write a Business Continuity Plan
How to write a Business Continuity PlanHow to write a Business Continuity Plan
How to write a Business Continuity Plan
 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck Presentation
 
Transcript: New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024Transcript: New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: Loan Stars - Tech Forum 2024
 
What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024
 
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
 
SAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptxSAP Build Work Zone - Overview L2-L3.pptx
SAP Build Work Zone - Overview L2-L3.pptx
 
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptxThe Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
The Fit for Passkeys for Employee and Consumer Sign-ins: FIDO Paris Seminar.pptx
 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine Tuning
 
DevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsDevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platforms
 
WordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your BrandWordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your Brand
 
Streamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project SetupStreamlining Python Development: A Guide to a Modern Project Setup
Streamlining Python Development: A Guide to a Modern Project Setup
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL Certs
 
Gen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfGen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdf
 
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
 
Digital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptxDigital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptx
 

Gaming for Good: Using Games to Create Change (Presented at SXSW 2015)

  • 1. #SXSW #games4good @HopeLab Gaming for Good Fred Dillon Director of Product Development HopeLab @FredDillon .
  • 8. Cancer Knowledge Baseline Follow-up Intervention-targetedknowledge(%correct) Control Re-Mission 55 60 65 70 Self-Efficacy Cancer-specificself-efficacy(1-7scale) 5.6 5.8 6.0 6.2 Baseline Follow-up Control Re-Mission p = .034 p = .027 30 40 CapEvents Antibiotics p = .008 P(log10) Re-Mission Chemotherapy: Oral 6MP p = .002 3.6 3.8 r Knowledge line Follow-up Control Re-Mission Self-Efficacy Cancer-specificself-efficacy(1-7scale) 5.6 5.8 6.0 6.2 Baseline Follow-up Control Re-Mission = .034 p = .027 ntibiotics p = .008 P(log10) Re-Mission Chemotherapy: Oral 6MP p = .002 3.6 3.8 Baseline Follow-up Intervention-targetedknowl Control Re-Mission 55 60 65 Cancer-specificself-effica 5.6 5.8 6.0 Base 0 10 20 30 40 TotalMEMSCapEvents Control Antibiotics p = .008 Plasma6MP(log10) Chemo 3.2 3.4 3.6 3.8 Base Baseline Follow-up Intervention-targetedknowl Control Re-Mission 55 60 65 Cancer-specificself-effica 5.6 5.8 6.0 Baseline Follow-up Control Re-Mission 0 10 20 30 40 TotalMEMSCapEvents Control Antibiotics p = .008 Plasma6MP(log10) Control Re-Mission Chemotherapy: Oral 6MP p = .002 3.2 3.4 3.6 3.8 Baseline Follow-up #SXSW #games4good @HopeLab Pediatrics – August 2008 Re-Mission Outcomes Study RCT 34 hospitals, 375 AYA with cancer
  • 9. Cancer Knowledge Baseline Follow-up Intervention-targetedknowledge(%correct) Control Re-Mission 55 60 65 70 Self-Efficacy Cancer-specificself-efficacy(1-7scale) 5.6 5.8 6.0 6.2 Baseline Follow-up Control Re-Mission p = .034 p = .027 30 40 CapEvents Antibiotics p = .008 P(log10) Re-Mission Chemotherapy: Oral 6MP p = .002 3.6 3.8 r Knowledge line Follow-up Control Re-Mission Self-Efficacy Cancer-specificself-efficacy(1-7scale) 5.6 5.8 6.0 6.2 Baseline Follow-up Control Re-Mission = .034 p = .027 ntibiotics p = .008 P(log10) Re-Mission Chemotherapy: Oral 6MP p = .002 3.6 3.8 Baseline Follow-up Intervention-targetedknowl Control Re-Mission 55 60 65 Cancer-specificself-effica 5.6 5.8 6.0 Base 0 10 20 30 40 TotalMEMSCapEvents Control Antibiotics p = .008 Plasma6MP(log10) Chemo 3.2 3.4 3.6 3.8 Base Baseline Follow-up Intervention-targetedknowl Control Re-Mission 55 60 65 Cancer-specificself-effica 5.6 5.8 6.0 Baseline Follow-up Control Re-Mission 0 10 20 30 40 TotalMEMSCapEvents Control Antibiotics p = .008 Plasma6MP(log10) Control Re-Mission Chemotherapy: Oral 6MP p = .002 3.2 3.4 3.6 3.8 Baseline Follow-up #SXSW #games4good @HopeLab Pediatrics – August 2008 Re-Mission Outcomes Study RCT 34 hospitals, 375 AYA with cancer
  • 10. Cancer Knowledge Baseline Follow-up Intervention-targetedknowledge(%correct) Control Re-Mission 55 60 65 70 Self-Efficacy Cancer-specificself-efficacy(1-7scale) 5.6 5.8 6.0 6.2 Baseline Follow-up Control Re-Mission p = .034 p = .027 30 40 CapEvents Antibiotics p = .008 P(log10) Re-Mission Chemotherapy: Oral 6MP p = .002 3.6 3.8 r Knowledge line Follow-up Control Re-Mission Self-Efficacy Cancer-specificself-efficacy(1-7scale) 5.6 5.8 6.0 6.2 Baseline Follow-up Control Re-Mission = .034 p = .027 ntibiotics p = .008 P(log10) Re-Mission Chemotherapy: Oral 6MP p = .002 3.6 3.8 Baseline Follow-up Intervention-targetedknowl Control Re-Mission 55 60 65 Cancer-specificself-effica 5.6 5.8 6.0 Base 0 10 20 30 40 TotalMEMSCapEvents Control Antibiotics p = .008 Plasma6MP(log10) Chemo 3.2 3.4 3.6 3.8 Base Baseline Follow-up Intervention-targetedknowl Control Re-Mission 55 60 65 Cancer-specificself-effica 5.6 5.8 6.0 Baseline Follow-up Control Re-Mission 0 10 20 30 40 TotalMEMSCapEvents Control Antibiotics p = .008 Plasma6MP(log10) Control Re-Mission Chemotherapy: Oral 6MP p = .002 3.2 3.4 3.6 3.8 Baseline Follow-up #SXSW #games4good @HopeLab Pediatrics – August 2008 Re-Mission Outcomes Study RCT 34 hospitals, 375 AYA with cancer
  • 11. Cancer Knowledge Baseline Follow-up Intervention-targetedknowledge(%correct) Control Re-Mission 55 60 65 70 Self-Efficacy Cancer-specificself-efficacy(1-7scale) 5.6 5.8 6.0 6.2 Baseline Follow-up Control Re-Mission p = .034 p = .027 30 40 CapEvents Antibiotics p = .008 P(log10) Re-Mission Chemotherapy: Oral 6MP p = .002 3.6 3.8 r Knowledge line Follow-up Control Re-Mission Self-Efficacy Cancer-specificself-efficacy(1-7scale) 5.6 5.8 6.0 6.2 Baseline Follow-up Control Re-Mission = .034 p = .027 ntibiotics p = .008 P(log10) Re-Mission Chemotherapy: Oral 6MP p = .002 3.6 3.8 Baseline Follow-up Intervention-targetedknowl Control Re-Mission 55 60 65 Cancer-specificself-effica 5.6 5.8 6.0 Base 0 10 20 30 40 TotalMEMSCapEvents Control Antibiotics p = .008 Plasma6MP(log10) Chemo 3.2 3.4 3.6 3.8 Base Baseline Follow-up Intervention-targetedknowl Control Re-Mission 55 60 65 Cancer-specificself-effica 5.6 5.8 6.0 Baseline Follow-up Control Re-Mission 0 10 20 30 40 TotalMEMSCapEvents Control Antibiotics p = .008 Plasma6MP(log10) Control Re-Mission Chemotherapy: Oral 6MP p = .002 3.2 3.4 3.6 3.8 Baseline Follow-up #SXSW #games4good @HopeLab Pediatrics – August 2008 Re-Mission Outcomes Study RCT 34 hospitals, 375 AYA with cancer
  • 12. PLOS ONE – March 2012 Re-Mission Attitudes Study #SXSW #games4good @HopeLab
  • 13. Playing PLOS ONE – March 2012 Re-Mission Attitudes Study #SXSW #games4good @HopeLab Motivation Excitement Memory
  • 14. Playing PLOS ONE – March 2012 Re-Mission Attitudes Study #SXSW #games4good @HopeLab Watching Motivation Excitement Memory
  • 17.
  • 18.
  • 19.
  • 20.
  • 21. ? … … … … …
  • 22. “I want to see the cancer blown up and vaporized!” #SXSW #games4good @HopeLab “I want to watch cancer squirm and suffer!” “Cancer is power hungry. It’s not satisfied with what it’s got, it always wants more.” “[Cancer] sits there and eats and takes from you and does nothing but eat and replicate.”
  • 23. #SXSW #games4good @HopeLab Cat God vs. Sun King

Editor's Notes

  1. Hi there. I’m Fred Dillon, the Director of Product Development at HopeLab, a non-profit research and development organization that works to harness the power of technology to improve health and well-being.
  2. HopeLab started with an idea. Our founder, Pam Omidyar, wondered: What if you used the power of videogames to help kids fight cancer? What if kids with cancer could actually blast away at their cancer cells? Could that actually have an impact on their health?
  3. Well we worked to answer that very question. Meet Liz and Nico. Nico was diagnosed with Leukemia when he was 7 years old.
  4. When he is released from the hospital he is asked to take chemotherapy pills everyday. Actually, a grand total of nearly 1100 pills over 3 years. [6MP (3 years’ worth – prescriptions typically 1-3/day, per Gary Dahl)]
  5. But if Nico is like most kids, he will miss some doses along the way. Here is what it looks like if he misses 20% of his prescribed treatments. Missing doses can be deadly. Missing 20% of doses can mean a 50% or greater chance of cancer coming back.
  6. That’s where Re-Mission comes in. How can a videogame change kids’ behaviors and get them to take their medications more regularly?
  7. In the original Re-Mission, released in 2005, kids pilot a nanobot named Roxxi through the bodies of kids with cancer, blasting cancer cells and helping to manage common side effects.
  8. And Re-Mission worked. In a randomized controlled trial, kids with cancer who played Re-Mission vs. those who played another game were found to have higher levels of cancer related knowledge.
  9. But, even more importantly, they had higher levels of self efficacy, the sense that they had a role to play in fighting their cancer and that they could do this.
  10. And they actually took their medications more regularly.
  11. We measured the amount of chemotherapy in their blood and the kids who played Re-Mission had higher levels than the control group.
  12. How is this possible and why did it work?
  13. We did some follow up studies using functional MRIs to look at that question. What we found is that when young people were playing the game, parts of their brains lit up related to motivation, excitement and memory.
  14. Other kids who watched video clips of the game play, but were not actually playing the game, did not have the same places lighting up. So the interactivity of the gameplay itself appears to have been key.
  15. So, what we have found is that Positive Emotions + Self Efficacy + a Shift in Attitudes among those who played the game were all essential ingredients to the recipe. And we then took those ingredients and applied them to the next iteration of the games, Re-Mission 2.
  16. By 2010, games had evolved since the development of Re-Mission.
  17. Games were more casual, more mobile.
  18. They were no longer tied to PCs or consoles.
  19. Players were enjoying short but powerful experiences, delivered wherever they are.
  20. In addition, we wanted to test out a new development model. In the more traditional model, someone has an idea and a couple of really creative folks get together and build something out, then they play test with their target audience somewhere around alpha or beta.
  21. We wanted to do something that honors the creative talents of people in the field, and our own focus on human-centered research Therefore our approach was: To engage with the audience early, understanding their needs, barriers to change, and then work to develop our ideas with them in mind Try something that was less expensive and had a shorter development cycle Leverage already existing fun games Here’s what we did…
  22. First we spent a lot of time talking to kids with cancer. What does cancer look like to them and what did they want to see in a cancer-fighting game? Insights informed game play style/action/effects. What’s fun for you, what games do you like? With all this in mind, what we did was go out into the space and look for games that were already popular and fun.
  23. This is Cat God vs. Sun King. It was popular on the flash game hosting site Kongregate. This was a proven game in terms of fun, audience appeal. Approachable game play with mechanics that we could see mapping onto battling cancer. We approached the developer, collaborated on “re-skinning” the game to the cancer-fighting context And what we came up with was Nanobot’s Revenge.
  24. This clip shows off some of key aspects that were changed: The minions building the tower have become cancer cells building a tumor to reach the bloodstream at the top and metastasize. The attacks have been rebranded and changed visually to be powerful chemo weapons informed by young people with cancer. Other parts haven’t really changed, but naturally map onto cancer treatment. Attacks cost energy, which must be managed. Just like in chemotherapy, you must keep your energy levels up to be able to handle chemo treatments. There are multiple different attacks which need to be used in combination to wipe out the enemy. Again, like in chemo where therapy consists of a cocktail of multiple drugs needed to bring Re-Mission. So by leveraging a pre-existing fun game with mechanics that map onto the behavior change we wanted to achieve, we were able to create 6 modern, accessible, and fun games much cheaper and faster than the original Re-Mission.
  25. Using this model, we developed 6 games in total, which you can experience (and play!) at ReMission2.org. As you can see from this experience, games can have a powerful impact on health behaviors and outcomes. I believe we are still at the beginning of innovative ways we can use games to improve the lives for millions of people around the world. I am excited to discuss this further later in this session.